Tower Research Capital LLC (Trc) Dr Reddys Laboratories LTD Transaction History
Tower Research Capital LLC (Trc)
- $3.53 Billion
- Q2 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 209 shares of RDY stock, worth $2,940. This represents 0.0% of its overall portfolio holdings.
Number of Shares
209Holding current value
$2,940% of portfolio
0.0%Shares
30 transactions
Others Institutions Holding RDY
# of Institutions
261Shares Held
92.4MCall Options Held
0Put Options Held
0-
Robeco Institutional Asset Management B.V.12.2MShares$171 Million0.3% of portfolio
-
Royal Bank Of Canada Toronto, A69.96MShares$140 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny9.01MShares$127 Million0.19% of portfolio
-
Aikya Investment Management LTD London, X06.35MShares$89.4 Million28.64% of portfolio
-
Dimensional Fund Advisors LP Austin, TX5.4MShares$76 Million0.02% of portfolio
About DR REDDYS LABORATORIES LTD
- Ticker RDY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 166,028,992
- Market Cap $2.34B
- Description
- Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...